Clinical trial consent for protocols and their revisions should be transparent for patients and
traceable for stakeholders. Our goal is to implement a process allowing for collection of …

The COVID-19 global pandemic continues to have devastating health, economic, and social
effects, and is profoundly affecting the delivery of health services. Because of the infection …

814 Stroke March 2017 prevention, acute treatment, and recovery/rehabilitation. This article
represents the collective thoughts of the NIH StrokeNet Recovery and Rehabilitation …

Stroke is a major burden to patients and society, and resources spent on stroke research
must be used efficiently and produce good value in terms of improvements in human health …

Globalization is rapidly changing lives and industries around the world. Drug development,
authorization, and regulatory supervision have become international endeavors, with most …

This paper addresses challenges of identifying, enrolling, and retaining participants in a trial
conducted within a routine care setting. All patients who are potential candidates for the …

Starting from historic reflections, the current SARS-CoV-2 induced COVID-19 pandemic is
examined from various perspectives, in terms of what it implies for the implementation of non …

BACKGROUND Duchenne muscular dystrophy (DMD) is a rare disease that causes the
progressive loss of motor abilities such as walking. Standard treatment includes …

This article applies 'outcome-driven innovation'methodology, developed by Anthony Ulwick
and popularised by Clayton Christensen, to the domain of clinical trials. Data were collected …

The proliferation of clinical trials in the last decade and the relatively limited number of
experienced clinical trial sites in comparison has created in some sites an environment of …